{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T01:57:07Z","timestamp":1760147827632,"version":"build-2065373602"},"reference-count":42,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["arthroplastyjournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Arthroplasty"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1016\/j.arth.2023.08.053","type":"journal-article","created":{"date-parts":[[2023,8,19]],"date-time":"2023-08-19T17:23:32Z","timestamp":1692465812000},"page":"307-312","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Treating Hepatitis C Before Total Knee Arthroplasty is Cost-Effective: A Markov Analysis"],"prefix":"10.1016","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0933-8537","authenticated-orcid":false,"given":"Gokul","family":"Kalyanasundaram","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James E.","family":"Feng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frank","family":"Congiusta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard","family":"Iorio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew","family":"DiCaprio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2683-9894","authenticated-orcid":false,"given":"Afshin A.","family":"Anoushiravani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.arth.2023.08.053_bib1","doi-asserted-by":"crossref","first-page":"S58","DOI":"10.1016\/j.jhep.2014.07.012","article-title":"Natural history of hepatitis C","volume":"61","author":"Westbrook","year":"2014","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.arth.2023.08.053_bib2","doi-asserted-by":"crossref","first-page":"831","DOI":"10.4254\/wjh.v7.i6.831","article-title":"Hepatitis C virus genetic variability and evolution","volume":"7","author":"Echeverr\u00eda","year":"2015","journal-title":"World J Hepatol"},{"key":"10.1016\/j.arth.2023.08.053_bib3","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1086\/428583","article-title":"Acute-phase hepatitis C virus infection: implications for research, diagnosis, and treatment","volume":"40","author":"Busch","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.arth.2023.08.053_bib4","doi-asserted-by":"crossref","first-page":"2249","DOI":"10.3390\/v13112249","article-title":"A Review on extrahepatic manifestations of chronic hepatitis C virus infection and the impact of direct-acting antiviral therapy","volume":"13","author":"Mazzaro","year":"2021","journal-title":"Viruses"},{"key":"10.1016\/j.arth.2023.08.053_bib5","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1002\/hep.30297","article-title":"Estimating prevalence of hepatitis C virus infection in the United States, 2013-2016","volume":"69","author":"Hofmeister","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.arth.2023.08.053_bib6","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1016\/j.arth.2012.05.016","article-title":"Prevalence of hepatitis C virus infection in the veteran population undergoing total joint arthroplasty","volume":"27","author":"Calore","year":"2012","journal-title":"J\u00a0Arthroplasty"},{"key":"10.1016\/j.arth.2023.08.053_bib7","first-page":"167","article-title":"Prevalence of hepatitis B and hepatitis C in an orthopaedics and traumatology ward","volume":"86","author":"Villani","year":"2001","journal-title":"Chir Organi Mov"},{"key":"10.1016\/j.arth.2023.08.053_bib8","doi-asserted-by":"crossref","first-page":"2890","DOI":"10.1016\/j.arth.2019.06.058","article-title":"Undetectable hepatitis C viral load is associated with improved outcomes following total joint arthroplasty","volume":"34","author":"Novikov","year":"2019","journal-title":"J\u00a0Arthroplasty"},{"key":"10.1016\/j.arth.2023.08.053_bib9","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1302\/0301-620X.101B6.BJJ-2018-0723.R3","article-title":"The preoperative management of Hepatitis C may improve the outcome after total knee arthroplasty","volume":"101-B","author":"Schwarzkopf","year":"2019","journal-title":"Bone Joint J"},{"issue":"7 Suppl 2","key":"10.1016\/j.arth.2023.08.053_bib10","doi-asserted-by":"crossref","first-page":"S84","DOI":"10.1016\/j.arth.2023.02.067","article-title":"Treating hepatitis C prior to total hip arthroplasty is cost effective: a markov analysis","volume":"38","author":"Anoushiravani","year":"2023","journal-title":"J\u00a0Arthroplasty"},{"key":"10.1016\/j.arth.2023.08.053_bib11","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1056\/NEJMoa020047","article-title":"Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection","volume":"347","author":"Fried","year":"2002","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.arth.2023.08.053_bib12","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1056\/NEJMoa1402454","article-title":"Ledipasvir and sofosbuvir for untreated HCV genotype 1 infection","volume":"370","author":"Afdhal","year":"2014","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.arth.2023.08.053_bib13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2106\/JBJS.RVW.20.00223","article-title":"Perioperative management of hepatitis C in patients undergoing total joint arthroplasty","volume":"9","author":"Ross","year":"2021","journal-title":"JBJS Rev"},{"key":"10.1016\/j.arth.2023.08.053_bib14","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.jhep.2018.03.026","article-title":"EASL recommendations on treatment of hepatitis C 2018","volume":"69","year":"2018","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.arth.2023.08.053_bib15","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1093\/cid\/ciu012","article-title":"Minimum costs for producing hepatitis C direct-acting antivirals for use in large-scale treatment access programs in developing countries","volume":"58","author":"Hill","year":"2014","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.arth.2023.08.053_bib16","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1186\/s12913-019-3956-x","article-title":"Short-term budget affordability of hepatitis C treatments for state Medicaid programs","volume":"19","author":"Chou","year":"2019","journal-title":"BMC Health Serv Res"},{"key":"10.1016\/j.arth.2023.08.053_bib17","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1016\/j.arth.2019.10.044","article-title":"Hospital Volume and postoperative infections in total knee arthroplasty","volume":"35","author":"Anis","year":"2020","journal-title":"J\u00a0Arthroplasty"},{"key":"10.1016\/j.arth.2023.08.053_bib18","doi-asserted-by":"crossref","first-page":"775","DOI":"10.2106\/JBJS.L.00211","article-title":"Risk factors associated with deep surgical site infections after primary total knee arthroplasty: an analysis of 56,216 knees","volume":"95","author":"Namba","year":"2013","journal-title":"J\u00a0Bone Joint Surg Am"},{"key":"10.1016\/j.arth.2023.08.053_bib19","doi-asserted-by":"crossref","first-page":"e4","DOI":"10.2106\/JBJS.RVW.18.00084","article-title":"Outcome of revision surgery for infection after total knee arthroplasty: results of 3 surgical strategies","volume":"7","author":"Leta","year":"2019","journal-title":"JBJS Rev"},{"key":"10.1016\/j.arth.2023.08.053_bib20","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.2106\/00004623-200306000-00003","article-title":"Above-the-knee amputation after a total knee replacement: prevalence, etiology, and functional outcome","volume":"85","author":"Sierra","year":"2003","journal-title":"J\u00a0Bone Joint Surg Am"},{"key":"10.1016\/j.arth.2023.08.053_bib21","doi-asserted-by":"crossref","first-page":"14","DOI":"10.2106\/JBJS.17.00874","article-title":"Reconsidering strategies for managing chronic periprosthetic joint infection in total knee arthroplasty: using Decision analytics to find the optimal strategy between one-stage and two-stage total knee revision","volume":"101","author":"Srivastava","year":"2019","journal-title":"J\u00a0Bone Joint Surg Am"},{"key":"10.1016\/j.arth.2023.08.053_bib22","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2019.24.30.1800695","article-title":"Mortality rates among individuals diagnosed with hepatitis C virus (HCV); an observational cohort study, England, 2008 to 2016","volume":"24","author":"Ireland","year":"2019","journal-title":"Euro Surveill"},{"key":"10.1016\/j.arth.2023.08.053_bib23","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1302\/2046-3758.911.BJR-2020-0343.R1","article-title":"Personalized estimation of one-year mortality risk after elective hip or knee arthroplasty for osteoarthritis","volume":"9","author":"Trela-Larsen","year":"2020","journal-title":"Bone Joint Res"},{"key":"10.1016\/j.arth.2023.08.053_bib24","doi-asserted-by":"crossref","first-page":"3783","DOI":"10.1016\/j.arth.2018.08.021","article-title":"Mortality during total knee periprosthetic joint infection","volume":"33","author":"Lum","year":"2018","journal-title":"J\u00a0Arthroplasty"},{"key":"10.1016\/j.arth.2023.08.053_bib25","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.ejvs.2013.03.024","article-title":"Short and long term mortality rates after a lower limb amputation","volume":"46","author":"Fortington","year":"2013","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.arth.2023.08.053_bib26","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1093\/cid\/ciz261","article-title":"Benefits and adverse events associated with extended antibiotic use in total knee arthroplasty periprosthetic joint infection","volume":"70","author":"Shah","year":"2020","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.arth.2023.08.053_bib27","article-title":"Quality-adjusted life years after hip and knee arthroplasty: health-related quality of life after 12,782 joint replacements","volume":"3","author":"Konopka","year":"2018","journal-title":"JB JS Open Access"},{"key":"10.1016\/j.arth.2023.08.053_bib28","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1177\/0272989X08315240","article-title":"Health-state utilities in liver disease: a systematic review","volume":"28","author":"McLernon","year":"2008","journal-title":"Med Decis Making"},{"key":"10.1016\/j.arth.2023.08.053_bib29","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1007\/s10198-019-01036-3","article-title":"Health state utilities associated with post-surgical Staphylococcus aureus infections","volume":"20","author":"Matza","year":"2019","journal-title":"Eur J Health Econ"},{"key":"10.1016\/j.arth.2023.08.053_bib30","doi-asserted-by":"crossref","first-page":"70","DOI":"10.2106\/JBJS.20.02221","article-title":"Development of a knee arthroplasty episode-based cost measure for evaluating cost in the merit-based Incentive payment system","volume":"104","author":"Choradia","year":"2022","journal-title":"J\u00a0Bone Joint Surg Am"},{"key":"10.1016\/j.arth.2023.08.053_bib31","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1186\/s13018-019-1224-8","article-title":"Economic burden of surgical site infections within the episode of care following joint replacement","volume":"14","author":"Adeyemi","year":"2019","journal-title":"J\u00a0Orthop Surg Res"},{"key":"10.1016\/j.arth.2023.08.053_bib32","doi-asserted-by":"crossref","first-page":"312","DOI":"10.2106\/JBJS.20.00550","article-title":"Direct Inpatient medical costs of operative treatment of periprosthetic hip and knee infections are twofold higher than those of aseptic revisions","volume":"103","author":"Yao","year":"2021","journal-title":"J\u00a0Bone Joint Surg Am"},{"author":"Administration","key":"10.1016\/j.arth.2023.08.053_bib33"},{"key":"10.1016\/j.arth.2023.08.053_bib34","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1001\/jama.2016.12195","article-title":"Recommendations for conduct, methodological practices, and reporting of cost-effectiveness analyses: second panel on cost-effectiveness in health and medicine","volume":"316","author":"Sanders","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.arth.2023.08.053_bib35","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1016\/j.arth.2015.02.017","article-title":"Updating cost effectiveness analyses in orthopedic surgery: resilience of the $50,000 per QALY threshold","volume":"30","author":"Nwachukwu","year":"2015","journal-title":"J\u00a0Arthroplasty"},{"key":"10.1016\/j.arth.2023.08.053_bib36","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1016\/j.jhep.2020.08.006","article-title":"Hepatic benefits of HCV cure","volume":"73","author":"Calvaruso","year":"2020","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.arth.2023.08.053_bib37","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.arth.2018.09.036","article-title":"Treatment for chronic hepatitis C prior to total hip arthroplasty significantly reduces periprosthetic joint infection","volume":"34","author":"Bedair","year":"2019","journal-title":"J\u00a0Arthroplasty"},{"key":"10.1016\/j.arth.2023.08.053_bib38","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1016\/j.arth.2022.04.027","article-title":"Antiviral treatment for hepatitis C is associated with a reduced risk of periprosthetic joint infection: a meta-analysis of observational studies","volume":"37","author":"Cheng","year":"2022","journal-title":"J\u00a0Arthroplasty"},{"key":"10.1016\/j.arth.2023.08.053_bib39","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1016\/j.arth.2020.12.025","article-title":"Hepatitis C antiviral treatment decreases all-cause complications after total joint arthroplasty regardless of the presence of fibrosis","volume":"36","author":"Cornell","year":"2021","journal-title":"J\u00a0Arthroplasty"},{"key":"10.1016\/j.arth.2023.08.053_bib40","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.15756","article-title":"Cost-effectiveness of universal and targeted hepatitis C virus screening in the United States","volume":"3","author":"Tatar","year":"2020","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.arth.2023.08.053_bib41","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr6902a1","article-title":"CDC recommendations for hepatitis C screening among adults - United States, 2020","volume":"69","author":"Schillie","year":"2020","journal-title":"MMWR Recomm Rep"},{"author":"Coalition","key":"10.1016\/j.arth.2023.08.053_bib42"}],"container-title":["The Journal of Arthroplasty"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0883540323008628?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0883540323008628?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T18:47:06Z","timestamp":1760122026000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0883540323008628"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":42,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,2]]}},"alternative-id":["S0883540323008628"],"URL":"https:\/\/doi.org\/10.1016\/j.arth.2023.08.053","relation":{},"ISSN":["0883-5403"],"issn-type":[{"type":"print","value":"0883-5403"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treating Hepatitis C Before Total Knee Arthroplasty is Cost-Effective: A Markov Analysis","name":"articletitle","label":"Article Title"},{"value":"The Journal of Arthroplasty","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.arth.2023.08.053","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}